Faruqi & Faruqi, LLP reminds investors of the August 17, 2026 deadline to seek lead plaintiff in a securities class action against Embecta Corp. The lawsuit alleges Embecta made false and misleading statements about its financial guidance, touting its pen needle business as "incredibly resolute" weeks before missing expectations and cutting fiscal 2026 guidance. On May 5, 2026, Embecta reported a revenue decline of over 14% for the second quarter, far exceeding its guided range of flat to a 2% decline, largely due to weakness in pen needle sales. The stock fell from $9.25 to $3.90 per share, a drop of over 57.8% in a single day. Investors who purchased Embecta securities between November 25, 2025 and May 4, 2026 may be eligible to participate.
Embecta CorpSecurities class action lawsuit alleging false financial guidance and missed revenue expectations, causing stock to drop 57.8%.